Abstract:Male reproductive toxicity examines harmful effects of various agents on all aspects and developmental stages of the male reproductive system, including germ cell development and spermatogenesis. In developing a model for reproductive toxicity screening it is important to define the developmental stage that this model is going to recreate in vitro and to identify critical molecular targets of this stage. In this review we focus our discussion on the potential for using embryonic stem cell (ESC)-derived models for male reproductive toxicity screening. The rationale for developing novel toxicity models is that despite significant advances in our biological understanding and clinical treatment of infertility, many unresolved cases still remain. This is likely due to our lack of knowledge about environmental influences on the critical stages of gamete development. Many practical and ethical difficulties are associated with the collection of human tissue samples to explore the unknown causes of infertility. Thus, a readily available in vitro model that mimics human gamete development would be an extremely valuable research tool for establishing novel toxicity assays. ESC exhibit a high degree of similarity with primordial germ cells (PGC) at the level of gene expression and molecular signaling. In addition, recent evidence shows that ESC can be differentiated into PGC and spermatids in culture. Multiple lines of evidence point to the differences between mouse and human ESC (hESC). In light of these data, we present the case that hESC are better suited as in vitro toxicity screening models than their mouse counterparts. We then describe some of the most promising hESC-based systems that are used today to model certain aspects of male gamete development and that have a potential to be used for toxicity screening. We conclude by discussing the potential of these existing models in toxicology studies and the possibilities for their improvement in the future.

Evaluation of human embryonic stem cells and their differentiated fibroblastic progenies as cellular models for in vitro genotoxicity screening.

Human Embryonic Stem Cells May Display Higher Resistance to Genotoxic Stress As Compared to Primary Explanted Somatic Cells.

Differentiated Fibroblastic Progenies of Human Embryonic Stem Cells for Toxicology Screening

Differential Resistance of Human Embryonic Stem Cells and Somatic Cell Types to Hydrogen Peroxide-Induced Genotoxicity May Be Dependent on Innate Basal Intracellular ROS Levels.

Comparison of the Response of Human Embryonic Stem Cells and Their Differentiated Progenies to Oxidative Stress

Cytotoxicity and Genotoxicity of Metal Oxide Nanoparticles in Human Pluripotent Stem Cell-Derived Fibroblasts

Evaluating Biotoxicity with Fibroblasts Derived from Human Embryonic Stem Cells.

Pluripotent Stem Cells: an in Vitro Model for Nanotoxicity Assessments

Establishment of drug screening in human embryonic stem cells based on a high-content screening system.

[Development of Human Embryonic Stem Cell Model for Toxicity Evaluation].

[Application of Keratinocytes Derived from Human Embryonic Stem Cells for Toxicological Evaluation of Drugs].

Use of Human Embryonic Stem Cell-based Models for Male Reproductive Toxicity Screening

Trace Levels of Mitomycin C Disrupt Genomic Integrity and Lead to DNA Damage Response Defect in Long-Term-cultured Human Embryonic Stem Cells.

[Development of Human Embryonic Stem Cell Platforms for Human Health-Safety Evaluation].

Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines

Differential Response of Human Embryonic Stem and Somatic Cells to Non-Cytotoxic Hydrogen Peroxide Exposure: An Attempt to Model In Vitro the Effects of Oxidative Stress on the Early Embryo

Suitability of Human Mesenchymal Stem Cells Derived from Fetal Umbilical Cord (Wharton’s Jelly) as an Alternative In Vitro Model for Acute Drug Toxicity Screening

Gene-modified embryonic stem cell test to characterize chemical risks

Modeling disease in human ESCs using an efficient BAC-based homologous recombination system.

Dissecting the Oncogenic and Tumorigenic Potential of Differentiated Human Induced Pluripotent Stem Cells and Human Embryonic Stem Cells

Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies